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Summary
Vertebrate gastrulation requires coordination of meso-
derm specification with morphogenetic movements.
While both of these processes require FGF signaling,
it is not known how mesoderm specification and cell
movements are coordinated during gastrulation. The
related Sprouty and Spred protein families are recently
discovered regulators of receptor tyrosine kinase sig-
naling. We identified two genes for each family in Xeno-
pus tropicalis: Xtsprouty1, Xtsprouty2, Xtspred1, and
Xtspred2. In gain- and loss-of-function experiments we
show that XtSprouty and XtSpred proteins modulate
different signaling pathways downstream of the FGF
receptor (FGFR), and consequently different develop-
mental processes. Notably, XtSproutys inhibit mor-
phogenesis and Ca2+ and PKC signaling, leaving MAPK
activation and mesoderm specification intact. In con-
trast, XtSpreds inhibit MAPK activation and meso-
derm specification, with little effect on Ca2+ or PKC
signaling. These differences, combined with the timing
of their developmental expression, suggest a mecha-
nism to switch FGFR signal interpretation to coordi-
nate mesoderm formation and cell movements dur-
ing gastrulation.
Introduction
The formation and patterning of mesoderm represents
a critical stage of vertebrate development. During gas-
trulation, mesodermal tissue must be coordinately in-
duced and directed through a series of morphogenetic
movements inside the embryo to form derivatives, such
as muscle, notochord, and blood. Completion of these
events is dependent on appropriate cellular responses
to signals from a relatively small number of growth
factors, including members of the fibroblast growth
factor family (FGFs) (Sivak and Amaya, 2004).
We have shown previously that disrupting FGF re-
ceptor (FGFR) signaling inhibits mesoderm induction
and maintenance (Amaya et al., 1991; Kroll and Amaya,
1996). The prominent pathway downstream of the*Correspondence: ea3@mole.bio.cam.ac.uk
3These authors contributed equally to this work.FGFR during this process is the ras/MAPK pathway
(Schlessinger, 2000). Inhibition of any component of
this pathway subsequently blocks the expression of
mesodermal markers (Gupta and Mayer, 1998; Mac-
Nicol et al., 1993; Tang et al., 1995; Whitman and Mel-
ton, 1992). FGF signaling has also been shown to di-
rectly affect morphogenetic cell movements during
gastrulation (Ciruna et al., 1997; Yang et al., 2002). We
have shown that this effect occurs through the FGFR
via a mechanism that is distinct from the ras/MAPK
pathway (Nutt et al., 2001). Therefore, FGFR signaling
is used both for maintaining mesoderm fate and for reg-
ulating morphogenesis. However, how does the embryo
interpret the signals correctly so that mesoderm main-
tenance and morphogenesis occur in a coordinated
fashion?
We have previously reported that the receptor tyro-
sine kinase (RTK) inhibitor protein, Xsprouty2, inhibits
FGFR- mediated morphogenesis but leaves mesoderm
formation intact (Nutt et al., 2001). The Sprouty family
was first discovered from a Drosophila mutation that
mimicked the effects of overactive FGF signaling (Ha-
cohen et al., 1998). A family of conserved Sprouty
genes have since been identified that act as intracellu-
lar inhibitors of RTK signaling, with homologs found in
mice, humans, zebrafish, and Xenopus (Christofori,
2003; Guy et al., 2003). Sprouty family members share
a conserved cysteine-rich carboxy-terminal domain
(Spry) and divergent amino termini (Guy et al., 2003).
Recently, a Sprouty-related family, the Spreds, has also
been described; they have been shown to inhibit RTK
signaling as well. Spreds share the Spry domain but
contain an N-terminal Enabled/VASP homology 1 do-
main (EVH1), and most have a binding sequence for
the oncogenic RTK c-kit (Kato et al., 2003; Wakioka et
al., 2001).
The biological roles of Sprouty and Spred proteins
remain unclear due to results suggesting they have a
variety of effects on RTK signaling. The majority of at-
tention has focused on inhibition of MAPK activation
by Sprouty proteins downstream of RTK signaling
(Casci et al., 1999; Hanafusa et al., 2002). However,
Sprouty family members have been shown to have vari-
able effects on MAPK activation and even enhance
MAPK signaling (Sasaki et al., 2001; Wong et al., 2002;
Yusoff et al., 2002). We have shown that Xsprouty2 ef-
fectively inhibits Ca2+ signaling but has little effect on
MAPK activation in vivo (Nutt et al., 2001). The Spreds
also inhibit MAPK activity and have been reported to
block activation of Raf (Kato et al., 2003; Wakioka et
al., 2001). Notably, mammalian Spreds have been ob-
served to be more potent inhibitors of MAPK activity
than Sproutys in vitro (Wakioka et al., 2001).
Here we have identified two members of each the
Sprouty and Spred families in the diploid frog Xenopus
tropicalis: Xtsprouty1 and Xtsprouty2 and Xtspred1 and
Xtspred2. Using both gain- and loss-of-function experi-
ments, we show that these two families of proteins help
modulate FGF signal interpretation in the early embryo
by inhibiting distinct downstream signal transduction
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pspecification and morphogenesis.
d
rResults
s
rFGFR Signaling Is Required for Morphogenesis
tbut Is Not Dependent on MAPK Activity
tWe have previously shown that Xsprouty2 inhibits FGF-
sdependent morphogenesis but does not affect meso-
rderm specification or MAPK activity in vivo. However,
the role of MAPK signaling during morphogenesis has
fremained unclear. We therefore conducted a series of
cexperiments to directly test the requirements of MAPK
Mactivation for morphogenetic movements during meso-
Mderm formation.
sFirst we determined the temporal profile of activated
iMAPK during the stages when morphogenetic move-
1ments are active during development, using antibodies
ospecific for activated MAPK (dp-MAPK). We found that
cMAPK was active at stage 11 during mesoderm specifi-
bcation, but activity decreased by stage 14, after meso-
derm had formed, and remained low until the late neu- s
srula stages (Figure 1A). In order to determine whetherFigure 1. Morphogenesis Requires FGFR Signaling Independent of MAPK
(A) Western blots against embryo lysates from various stages probed for active MAPK (dp-MAPK) and pan-MAPK. MAPK activity peaked at
stage 11 and decreased by stage 14, and then returned at stage 19.
(B) Blots for dp-MAPK and pan-MAPK against DMZ lysates at corresponding stages. Again, MAPK activity peaked at stage 11 and decreased
sharply at stage 12, remaining low until stage 18.
(C) DMZ extension (m) plotted against the corresponding stage. The majority of extension occurred between stages 12–16. Error bars
represent standard deviation.
(D) dp-MAPK blots from animal cap lysates incubated for 15 min with and without FGF2 in the presence of increasing concentrations of
FGFR1 inhibitor (SU5402) or MEK1 inhibitor (U0126). Both drugs abolished FGF-induced MAPK activation in a dosage-dependent manner.
(E) Embryos injected with 10 nl of 2 mM SU5402, U0126, or DMSO into the blastocell and cultured with the same inhibitor at stage 8 or 12.5.
Stage 8 treated embryos were fixed at stage 11.5 and 29–30 for in situ hybridization for Xbra and cardiac actin, respectively. Both inhibitors
blocked mesoderm specification and gastrulation movements when treated at stage 8. Embryos treated at stage 12.5 with SU5402 exhibited
morphogenetic defects, but U0126-treated were unaffected.APK was active in the tissues undergoing active mor-
hogenesis, we assayed MAPK activity in dissected
orsal marginal zone (DMZ) explants. Consistent with
esults from whole embryos, MAPK activity peaked in
tage 11 DMZs and decreased by stage 12, where it
emained low until stage 18 (Figure 1B). Notably, during
he stages when MAPK activity was low we found that
he DMZs were most actively undergoing morphogene-
is (Figure 1C), suggesting that MAPK signaling is not
equired for this process.
To determine whether FGFR signaling is necessary
or morphogenesis independently of MAPK, we used
hemical inhibitors of the FGF receptor (SU5402) and
EK1 (U01236) to disrupt all FGFR activity or just
APK activation, respectively. Both SU5402 and U0126
uccessfully inhibited FGF-stimulated MAPK activation
n animal caps in a dose-dependent manner (Figure
D). Embryos were then treated with SU5402, U0126,
r DMSO control at stage 8 (before mesoderm specifi-
ation) and stage 12.5 (after mesoderm specification,
ut prior to the stages of most extensive morphogene-
is). Embryos exposed to either SU5402 or U0126 at
tage 8 failed to complete gastrulation, resulting in an
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691open blastopore phenotype with decreased expression
of mesodermal markers Xbrachyury (Xbra) and cardiac
actin (Figure 1E) (percentage of open blastopore phe-
notypes: 0% [n = 48] in DMSO; 76.6% [n = 47] in
SU5402; 84.4% [n = 45] in U0126)]. These results are
consistent with the effects of disrupting the FGFR or
ras/MAPK pathway during early stages of develop-
ment. In comparison, embryos treated with the FGFR
inhibitor (SU5402) at stage 12.5 showed morphogenetic
defects resulting in a shortened anterior-posterior (A-P)
axis, whereas embryos treated with the MAPK inhibitor
(U0126) developed normally (Figure 1E) (percentage
shorter than 4.5 mm at stage 29–30: 0% [n = 40] in
DMSO; 92.3% [n = 29] in SU5402; 2.5% [n = 40] in
U0126). Taken together, these results show that FGFR
signaling is required for both mesoderm specification
and morphogenesis, but only mesoderm specification
depends on MAPK activity, suggesting that morpho-
genesis involves an alternate downstream pathway.
Xtsproutys and Xtspreds Are Related Families of
FGFR Regulatory Genes that Share Overlapping
Expression Patterns, but at Slightly Different Times
Based on our previous work, we hypothesized that
Sprouty family members may be involved in regulating
FGFR signal interpretation during development. We
isolated two X. tropicalis sprouty genes, Xtsprouty1
(Xtspry1) and Xtsprouty2 (Xtspry2), and two related spred
genes, Xtspred1 (Xtsprd1) and Xtspred2 (Xtsprd2). As
with their mammalian counterparts, all the identified
XtSprouty and XtSpred proteins share a conserved cys-
teine-rich C-terminal Spry domain. The two Sprouty
proteins contain an uncharacterized N-terminal domain
whose function remains obscure (Guy et al., 2003),
while the two Spreds contain an N-terminal EVH1 do-
main and c-Kit binding domain (KBD) (Harmer et al.,
2005; Wakioka et al., 2001) (Figure 2A). All proteins con-
tain a high degree of identity to their human counter-
parts: 72.9% for Sprouty1, 72.7% for Sprouty2, 60.1%
for Spred1, and 69.9% for Spred2.
The Xtsprouty and Xtspred genes are all expressed
in broadly similar patterns to X. laevis sprouty2 and a
number of FGFs, including XFGF8, XeFGF, and FGF-9
(Christen and Slack, 1997; Isaacs et al., 1994; Nutt et al.,
2001; Song and Slack, 1996). During gastrula stages, ex-
pression was first localized to the dorsal marginal zone,
but later expanded laterally and ventrally. Although all
four genes displayed this pattern, Xtspry1 and Xtspry2
were detected earlier and expanded their expression
pattern more quickly than Xtsprd1 and Xtsprd2 (Figure
2B). During neurula stages, expression became con-
fined anteriorly and posteriorly and expanded to vary-
ing degrees along the neural tube. Generally, staining
for Xtsproutys became weaker and more localized,
while Xtspreds became stronger and more broad. At
tail bud stages, staining became localized to the de-
veloping branchial arches, forebrain, otic vesicle, mid-
brain/hindbrain isthmus, and tail bud. Xtspry2 staining
was absent from the third branchial arch; however, this
feature was stained for Xtspry1, Xtsprd1, and Xtsprd2
mRNAs. Comparatively, Xtspred gene expression over-
lapped considerably with the Xtsprouty genes, with the
exception that staining for the Xtspred genes was eitherweak or absent in the midbrain/hindbrain isthmus and
forebrain and did not extend as far posteriorly in the
tail bud.
We next decided to determine whether the Xtsprouty
and Xtspred genes are expressed at the same relative
times. Since in situ hybridization data are not quantita-
tive, we decided to answer this question using quanti-
tative real-time RT-PCR. We found that, although the
Xtsprouty and Xtspred genes share similar spatial pat-
terns, they have important temporal differences. The
relative expression levels by real-time RT-PCR of
Xtspry1 and Xtspry2 was higher during early gastrula
stages and then decreased, while Xtsprd1 and Xtsprd2
remained low during the early gastrula stages but in-
creased significantly from the end of gastrulation
through neurula stages (Figure 2C).
XtSprouty and XtSpred Gain-of-Function
Experiments Cause Distinct Phenotypes
To begin to address the function of these genes, we
injected in vitro transcribed mRNAs corresponding to
the Xtsprouty and Xtspred genes into the dorsal mar-
ginal zones of X. laevis embryos at the two-cell stage.
Embryos injected with Xtsproutys developed a short-
ened A-P axis, compared to controls injected with a
nonfunctional FGF receptor (HAV\) or uninjected em-
bryos (Figures 3A and 3B). Interestingly, this phenotype
is similar to that caused by treatment with an FGFR
inhibitor at stage 12.5 (Figure 1E). In comparison, em-
bryos injected with Xtspreds developed an open blas-
topore phenotype reminiscent of the effects of early
FGFR inhibition (Figure 1E). These results prompted
further investigations to determine if the differences be-
tween the Xtsproutys and Xtspreds were variations in
severity of the same phenotype or caused by distinct
underlying molecular mechanisms.
XtSpreds Inhibit Mesoderm Specification
but XtSproutys Do Not
Early disruption of FGFR function blocks specification
of mesoderm as well as failure to complete gastrula-
tion. This effect is due to interruption of the MAPK sig-
naling cascade controlling transcriptional activation of
mesodermal genes, such as the T-box transcription
factor Xbrachyury (Xbra) (Sivak and Amaya, 2004). We
tested the effects of Xtsprouty and Xtspred overexpres-
sion on mesoderm specification and MAPK activity. A
series of in situ hybridizations was carried out for Xbra
on mid-gastrula embryos that had been coinjected with
either Xtsprouty or Xtspred, and β-gal RNAs into one
blastomere at the two-cell stage. Control-injected em-
bryos showed a characteristic ring of Xbra expression
in the marginal zone around the blastopore. Injections
of either Xtsprouty had little effect on Xbra; however,
both Xtspreds completely blocked Xbra expression on
the injected side (Figure 3C).
We then assayed the effects of XtSprouty and
XtSpred proteins on MAPK activity, using the dp-MAPK
antibody. As shown previously, during gastrulation
there is a sharp FGF-dependent increase in the amount
of activated MAPK, concomitant with mesoderm speci-
fication (Figure 1A). When 1.0 ng RNAs was injected
into both blastomeres, neither XtSprouty had an effect
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(A) Cartoon depiction of domain structures for each protein. Spry, conserved Sprouty domain; EVH-1, VASP homology domain; KBD, c-Kit
binding domain.
(B) In situ hybridizations for each gene. At gastrula stages (stage 10.5), Xtsproutys showed more extensive staining around the blastopore
than Xtspreds (arrow). Neurula stages showed increased staining of Xtspreds and decreased Xtsproutys. Tail bud stages showed similar
staining in branchial arches (br), otic vesicle (ov), and tail bud (tb), but Xtspred staining was absent in mid-brain/hind-brain isthmus (mhb)
and forebrain (fb).
(C) Quantitative real-time RT-PCR analysis of each gene’s expression over time. Relative expression levels showed Xtsproutys peak before
stage 12.5 and then diminish, while Xtspreds levels increased after stage 12.5.on MAPK activity. However, both XtSpred proteins T
eblocked MAPK signaling as efficiently as the dominant-
negative FGF receptor (XFD) (Figure 3D). Since Sprouty p
mproteins have been studied as inhibitors of the MAPK
signaling pathway in vitro, we tested the possibility that h
2the XtSproutys might be more effective at inhibiting
MAPK activation at higher concentrations. A dosage
vseries with the most effective family member, Xtspry2,
was able to slightly reduce MAPK activation at the 3
ehighest amount tested (2 ng), but Xtsprd1 completely
abolished MAPK activation even at 1 ng (Figure 3E). dhis suggests that the XtSpred proteins are much more
ffective inhibitors of MAPK signaling than the XtSprouty
roteins in vivo. Others have similarly reported that
ammalian Spred proteins are more effective MAPK in-
ibitors than the Sprouty proteins (Wakioka et al.,
001).
We also tested the effect of FGF-induced MAPK acti-
ation in animal caps. Compared to the results in Figure
D, which tested steady state MAPK activity in whole
mbryos, this experiment directly tested the FGF-
ependent activation of MAPK in animal caps after 15
FGF Signal Interpretation by Sprys/Sprds
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(A) Stage 33–34 embryos after injection with 1 ng of indicated RNAs at the two-cell stage in the dorsal marginal zone. Xtspry1- and Xtspry2-
injected embryos displayed a shortened A-P axis, while Xtsprd1- and Xtsprd2-injected embryos developed an open blastopore.
(B) Quantification of overexpression phenotypes, sorted into wild-type, shortened, and open blastopore categories.
(C) Embryos coinjected with RNAs and β-gal into one blastomere at the two-cell stage. X-gal staining (blue, arrows) and in situ hybridization
for Xbra (purple) at the mid-gastrula (stage 11) showed that both Xtsprd1 and Xtsprd2 blocked Xbra expression but Xtspry1 and Xtspry2 had
little effect.
(D) Western blots of lysates from stage 11 embryos injected into both blastomeres and probed for dp-MAPK or pan-MAPK. HAV\ control
showed a dp-MAPK band that was blocked by XtSprd1, XtSprd2, and dnFGFR (XFD). XtSpry1 and XtSpry2 had no effect on MAPK activation.
(E) Dosage series of lysates from stage 11 embryos injected as above with 0.25, 1.0, and 2.0 ng RNAs. XtSprd1 was much more effective
than XtSpry2 at reducing dp-MAPK signal.
(F) Blot of animal cap lysates cultured with and without FGF2 for 15 min and then probed for dp-MAPK. HAV\ control showed an increase of
dp-MAPK when FGF2 treated. This signal was absent from caps injected with Xtsprd1 and XFD, but not from caps injected with Xtspry2. UI,
uninjected embryo; HAV\, control RNA; XFD, dominant-negative FGFR.min. As expected, untreated caps did not contain acti-
vated MAPK. Addition of FGF2 to control-injected caps
led to a clear increase in activated MAPK, which was
blocked by injection of dnFGFR (XFD). MAPK activation
was largely unaffected by injection of 1.0 ng Xtspry2
RNA but was blocked by Xtsprd1 (Figure 3F).
XtSproutys Inhibit Morphogenesis Independently
of Mesoderm Specification
We tested the effects of the Xtsproutys and Xtspreds
on morphogenesis using an animal cap assay. Animal
caps were dissected from injected embryos and cul-
tured in the presence or absence of activin. Underactivin treatment, control caps express mesodermal
markers and undergo FGF-dependent convergent ex-
tension movements (Cornell and Kimelman, 1994). In
this experiment the most effective members of each
family, Xtspry2 and Xtsprd1, were injected into animal
poles. Each resulted in inhibition of cap extension in
the presence of activin (Figure 4A). In light of the phe-
notypic differences we had observed, we wondered
whether the inhibition of cap extension was due to the
same underlying factors. RT-PCR was performed on
gastrula (stage 11) caps injected as above with primers
amplifying the mesodermal marker Xbra (Figure 4B). As
expected, HAV\ control caps showed little Xbra expres-
Developmental Cell
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(A) Animal caps cultured with and without activin until mid-neurula stages. Caps injected with HAV\ control extended when treated with
activin, but Xtspry2- or Xtsprd1-injected caps did not.
(B) RT-PCR results from stage 11 animal caps injected as above. Activin treatment increased Xbra expression in HAVØ controls. Xtspry2
increased Xbra expression in untreated caps, but had no effect after activin treatment. Xtsprd1 inhibited Xbra expression with activin.
(C) Oocyte assay of Ca2+ signaling. Release of 45Ca2+ from oocytes coinjected with constitutively active FGFR (CIXR) and the indicated RNAs
was counted after 10 min. Addition of CIXR increased 45Ca2+ release 5-fold (HAV\). Coexpression of dominant-negative CIXR (CIXD), Xtspry1,
Xtspry2, or X. laevis Sprouty2 (Xspry2) effectively blocked this increase. Xtsprd1 had significantly less effect, and Xtsprd2 and Xtsef had no
effect. Error bars represent standard deviation.
(D) Confocal images of PKCδ-GFP expressed in animal caps and cultured for 10 min in the presence of either 1 M PMA, 100 ng/ml FGF2, or
coexpressed XtSpry2 or XtSprd1 as indicated. PKCδ was activated by both PMA and FGF2 and localized to the membrane. XtSpry2 inhibited
FGF-induced localization of PKCδ but XtSprd1 did not.sion unless treated with activin to induce mesoderm. i
XXtspry2 had no effect on Xbra induction with activin,
and surprisingly caused an increase in Xbra expression tn the absence of activin. In comparison, injection of
tsprd1 inhibited the induction of Xbra after activin
reatment. Therefore, morphogenetic extension was
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695blocked in Xtspry2- injected caps even though they still
contained mesoderm, while the Xtsprd1-injected caps
did not extend, but also lacked mesoderm.
XtSproutys Are More Effective Inhibitors of Ca2+
Signaling than XtSpreds
The MAPK cascade is only one of several signaling
pathways that can be induced following FGFR activa-
tion. Another prominent downstream pathway acts
through phospholipase Cγ (PLCγ). PLCγ hydrolyzes
phosphatidylinositol into diacylglycerol (DAG) and ino-
sitol trisphosphate (IP3), which activates the IP3 recep-
tor in the endoplasmic reticulum, causing an efflux of
Ca2+ into the cytoplasm (Schlessinger, 2000). Localized
Ca2+ signaling has been linked to convergent extension
movements during Xenopus gastrulation (Wallingford et
al., 2001). We have previously reported that X. laevis
Sprouty2 inhibits FGF-induced Ca2+ mobilization in an
efflux assay using Xenopus oocytes (Nutt et al., 2001).
Using the same assay we compared the effect of the
XtSprouty and XtSpred proteins on FGFR-induced Ca2+
release. Both XtSpry1 and XtSpry2 were as effective as
X. laevis Spry2 in blocking Ca2+ release (Figure 4C). In
contrast, XtSprd1 only partially inhibited Ca2+ release
and XtSprd2 was ineffective. A negative control was
provided by XtSef, an inhibitor of FGFR signaling that
targets the Ras/MAPK pathway and bears no homology
to the Sprouty family (Furthauer et al., 2002). These re-
sults provide additional evidence that XtSprouty and
XtSpred proteins target different signaling pathways
downstream of FGFR activation.
FGF-Induced PKC Localization Is Inhibited
by XtSproutys but Not by XtSpreds
Another important secondary messenger produced by
PLCγ in addition to IP3 is DAG. The most prominent
intracellular targets of DAG belong to the protein kinase
C (PKC) family. Kinoshita et al. (2003) recently demon-
strated that upon activation, PKCδ, a member of the
novel (nPKC) subfamily, translocates to the cell mem-
brane where it is an essential component of the nonca-
nonical Wnt, or planar cell polarity, signaling pathway.
Inhibition of PKCδ disrupts convergent extension move-
ments during gastrulation, but does not block the expres-
sion of mesodermal markers (Kinoshita et al., 2003).
Given the similarities of these results to our observa-
tions with XtSproutys, and that nPKC proteins rely
solely on DAG for activation (Gschwendt, 1999), we
tested whether FGFR signaling can activate PKCδ.
Membrane localization of GFP-tagged PKCδ was ob-
served in animal caps using confocal microscopy (Fig-
ure 4D). PKCδ-GFP signal was diffuse in untreated
caps, but addition of phorbol 12-myristate 13-acetate
(PMA), a DAG analog, caused its translocation to cell
membranes. Interestingly, addition of FGF2 also caused
PKCδ-GFP to localize to the membrane. This localiza-
tion was inhibited if XtSpry2 was coexpressed with
PKCδ-GFP, but not when coexpressed with XtSprd1
(Figure 4D). These results provide additional evidence
that XtSproutys target a distinct PLCγ-mediated signal-
ing pathway compared with XtSpreds downstream of
the FGFR.Loss of XtSprouty and XtSpred Functions Causes
Distinct Phenotypes
Loss-of-function experiments were conducted for Xt-
Sprouty and XtSpred proteins using antisense morpho-
lino oligonucleotides (MOs). We have previously used
this technique to effectively abrogate RNA translation
and/or splicing by injecting MOs directly into early em-
bryos (Kenwrick et al., 2004). MO sequences were de-
signed to specifically target splice junctions for each
Xtsprouty and Xtspred pre-mRNA. A cartoon depicting
the design and targeting of splice morpholinos is
shown in Figure 5A. Each MO sequence was desig-
nated by its target location (e.g., e1i1 for the exon1-
intron1 boundary, i1e2 for the intron1-exon2 boundary,
etc.). We confirmed the effectiveness of the morpho-
linos by assaying for splicing interference by perform-
ing RT-PCR using primers across each splice junction.
Affected transcripts either amplified at different sizes
or failed to amplify (Figure 5B).
X. tropicalis embryos were used for these experi-
ments as their diploid genome allows for much simpler
loss-of-function interpretation than the allotetraploid X.
laevis. In each experiment, MOs were injected into zy-
gotes before first cleavage. As a control, a MO contain-
ing four mismatches to the Xtspry2 sequence (4-mis)
was used. Injection of MOs targeted to the Xtsprouty
and Xtspred genes developed markedly different phe-
notypes (Figures 5C and 5E). In these experiments,
combinations of splice MOs were used in order to re-
duce the effects of functional redundancy between
family members. A combination of Xtspry1 and Xtspry2
MOs (Spry1 i1e2 and Spry2 e1i1) caused anterior-pos-
terior truncations. These results were similar to the
gain-of-function effect (Figure 3A), which might be ex-
pected if coordination of morphogenesis was dis-
rupted. In contrast, MOs targeting the Xtspred genes
(using a combination of Sprd1 e1i1 and Sprd2 e2i2
MOs) produced a more severe phenotype, with em-
bryos appearing ventro-posteriorized (Figures 5C and
5E). This effect is reminiscent of that reported for em-
bryos with overactive FGFR signaling (Isaacs et al.,
1994). Xtsprd MO-injected embryos had diffuse and
weak cardiac actin staining and had either absent or
undifferentiated notochords (Figures 5C and 5D). Simi-
larly, Xtsprd MO embryos showed no staining for the
notochord marker FK506 binding protein (Spokony and
Saint-Jeannet, 2000) (Figures 5E and 5F). In contrast,
Xtspry MO-injected embryos stained normally for
cardiac actin expression and the notochord was clearly
visible (Figures 5C–5F).
XtSprouty Depletion Causes Animal Caps
to Undergo Morphogenetic Extension, while
XtSpred Depletion Inhibits Extension
Animal caps isolated from MO-injected embryos were in-
cubated with and without activin (10 ng/ml) and assayed
for extension. Both uninjected and 4-mis-injected caps
remained as rounded balls when left untreated but elon-
gated in the presence of activin (Figure 6A). However,
animal caps isolated from Xtsprouty and Xtspred de-
pleted embryos had strikingly different outcomes. Caps
injected with combined Spry1 and Spry2 splice MOs
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(A) Cartoon depicting splice MO designs at either end of splice junctions.
(B) RT-PCRs of MO-injected embryos. MO-injected lanes show bands either absent or shifted (arrowheads).
(C and E) Embryos injected with MOs before first cleavage assayed for cardiac actin and FK506bp expression at stage 35 by in situ hybridiza-
tion (purple). Embryos injected with 4-mis control MOs appeared identical to uninjected embryos (UI). Injection of combined Spry1 and
Spry2 MOs (Spry 1+2) produced a truncated phenotype, while injection of Sprd1 and Sprd2 MOs (Sprd 1+2) produced a severe ventro-
posteriorized phenotype.
(D and F) Corresponding crosssections through trunks of embryos injected as above. Spry MO embryos appeared relatively normal in
crosssection, but Sprd MO embryos showed disrupted somites and absence of a notochord (arrowhead).elongated in the absence of activin, but Sprd1 and v
eSprd2 splice MO caps failed to extend significantly in
the presence of activin (Figure 6A). In order to con- m
sfirm that we had specifically reduced XtSprouty and
XtSpred protein function, we designed another set of e
aMOs to these genes, targeting the start ATGs of each
mRNA to inhibit translation. Similar to splice MOs, in- e
ajection of Spry2 ATG MOs also induced cap extension
in the absence of activin, while Sprd1 ATG MOs inhib- h
mited extension with activin (Figures 6B and 6C). There-
fore, two different MOs targeting separate regions of t
othe mRNAs caused the same phenotypes, confirming
the specificity of the experiments. The resulting animal C
scap extensions of MO-injected embryos are summa-
rized in Figure 6C. d
tExtension of animal caps in the absence of activin
was an unexpected and unusual result. We wondered c
mwhether the XtSprouty depleted animal caps also de-eloped mesoderm in the absence of activin. Therefore,
xpression of mesodermal markers was checked in ani-
al caps at mid-gastrula stages by RT-PCR. In the ab-
ence of activin, both uninjected and 4-mis-injected
mbryos expressed a small amount of Xtbra, Xtwnt11,
nd Xtwnt8 message (Figure 6D). This amount is not
nough to convert the tissue to mesoderm. Although
nimal caps depleted for XtSproutys elongated, they
ad little increase in the expression of these early
esoderm markers. Therefore, loss of XtSprouty func-
ion allowed morphogenetic movements to occur with-
ut a significant increase in mesoderm specification.
onversely, XtSpred depleted animal caps exhibited a
ignificant increase in the expression of these meso-
erm markers in the absence of activin, but did not ex-
end. Therefore, loss of XtSpred function allowed an in-
rease in mesoderm specification without induction of
orphogenetic movements. Taken together, these re-
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697Figure 6. XtSprouty Depletion Causes Animal Caps To Extend, but XtSpred Depletion Inhibits Cap Extension
(A) Animal cap assays with and without activin treatment following MO injection. 4-mis control-injected caps extended after activin treatment.
Combined XtSprouty1+2 splice MO-injected caps extended in the absence of activin, while XtSpred1+2 splice MO-injected caps were inhib-
ited from extending after activin treatment.
(B) Assays as above using ATG MOs showed similar results to splice MOs.
(C) Summary of animal cap extension results indicating percent of caps remaining round (-), starting to extend (+), and clearly extended (++).
(D) RT-PCR results for Xtbra, Xtwnt11, Xtwnt8, and EF1a expression in MO-injected caps with and without activin. Caps injected with Spred
MOs strongly expressed these mesodermal markers even when untreated, but Spry MOs had little effect on the expression of these markers.sults support the differences observed from mis-expres-
sion experiments: XtSproutys inhibit a branch of FGFR
signaling that regulates morphogenesis, while the
XtSpreds regulate mesoderm specification.
Discussion
In recent years, it has become apparent that a great
variety of developmental decisions are controlled byonly a handful of morphogenic signals. For example,
RTK activation by the FGF family of secreted factors
has been implicated in cell differentiation, growth, mi-
gration, wound healing, and angiogenesis (Robertson
et al., 2000; Schlessinger, 2000; Sivak and Amaya,
2004). In some cases FGFs are used for multiple deci-
sions at essentially the same time (Sivak and Amaya,
2004). Therefore, an important question arises: how can
the same signal be interpreted as performing different
Developmental Cell
698Figure 7. Model of Sprouty and Spred Regu-
lated Switching of FGFR Signal Pathways
(A) Xtsproutys are expressed first, resulting in
inhibition of the PLCγ/morphogenesis pathway
downstream of the FGFR while the MAPK/
mesoderm specification pathway proceeds.
(B) As mesoderm specification finishes,
Xtspred expression increases, resulting in in-
hibition of the mesoderm specification path-
way. At this point expression of Xtsproutys
diminishes, allowing the morphogenesis
pathway to proceed.functions, often within the same cells? The related m
hSprouty and Spred families are recently discovered pro-
cteins that function to directly regulate RTK signaling
vdownstream of receptor activation (Christofori, 2003;
2Guy et al., 2003). Here we have described divergent
troles for Sproutys and Spreds in regulation of FGFR
fsignaling during vertebrate gastrulation: XtSprouty pro-
tteins inhibit morphogenesis, PKCδ activation, and Ca2+
lsignaling, and XtSpreds inhibit mesoderm specification
pand MAPK activation. In this manner XtSproutys and
XtSpreds can switch between activation of two FGFR
tsignal pathways to coordinate distinct developmental
hevents.
E
dFunctional Divergence of Xtsprouty
band Xtspred Proteins
dGain- and loss-of-function experiments revealed marked
tdifferences between XtSprouty and XtSpred functions
cin vivo. Xtsprouty misexpression resulted in shortened
iembryos and inhibited morphogenic movements but left
smesoderm formation intact. FGFR-dependent MAPK ac-
2tivation was only weakly affected, but PKCδ activation
X
and Ca2+ signaling were strongly inhibited. Notably, Xbra
i
was induced in untreated animal caps overexpressing
t
Xtspry2, suggesting that in this context XtSprouty pro- D
teins can actually enhance the mesoderm specification e
pathway. Conversely, XtSprouty depletion caused un- o
treated animal caps to undergo morphogenetic exten- L
sions without an accompanying increase in mesoderm. w
This striking result is similar to the one observed when w
an activated version of protein-tyrosine phosphatase c
SHP-2 is missexpressed in animal caps (O’Reilly et al., X
2000). Interestingly, this same activated version of SHP-2
has recently been shown to dephosphorylate and inac- b
tivate Sprouty (Hanafusa et al., 2004). Therefore, it may t
be possible that untreated animal caps expressing acti- a
vated SHP-2 elongate because Sprouty is inactivated, a
a question that is now being investigated. a
In other model systems Sproutys have also consis- W
tently been associated with morphogenesis and cell i
migration, processes not normally associated with s
MAPK signaling (Lim et al., 2000; Yigzaw et al., 2001, t
2003). In particular, depletion of Sproutys has been re- t
ported to cause excessive morphogenesis in mice and d
flies (Hacohen et al., 1998; Tefft et al., 1999). The animal t
cap extensions we observed after XtSprouty depletion b
is reminiscent of these other cases. We have shown S
here that XtSproutys are efficient inhibitors of FGFR- c
vdependent Ca2+ signaling and PKCδ activation, twoajor outcomes of PLCγ activation. Importantly, PKCδ
as recently been demonstrated to be an essential
omponent of the wnt/planar cell polarity pathway in-
olved in regulating morphogenesis (Kinoshita et al.,
003). Ca2+ signaling has also been implicated in con-
rol of convergent extension movements without af-
ecting cell fate (Wallingford et al., 2001). Therefore,
hese results provide evidence of a mechanism directly
inking FGFR signaling to cell migration/cell polarity
athways.
In contrast, XtSpreds inhibited mesoderm differentia-
ion through strong inhibition of MAPK activation and
ad little effect on Ca2+ signaling or PKCδ activation.
mbryos injected with Xtspred1 and Xtspred2 RNAs
id not develop mesoderm and displayed an open
lastopore phenotype reminiscent of the effect of
nFGFR (Amaya et al., 1991). Likewise, XtSpred pro-
eins blocked MAPK activity and extension in animal
aps. These results are consistent with studies show-
ng that mammalian Spreds inhibit Raf activation up-
tream of MAPK (Kato et al., 2003; Wakioka et al.,
001). Interestingly, the timing of expression of the
tspred genes correlates with the loss of MAPK activity
n embryos, suggesting that the decrease in MAPK ac-
ivity is due to the expression of the Xtspred genes.
epletion of XtSpreds resulted in ventro-posteriorized
mbryos that lacked a notochord, similar to the effect
f constitutive FGFR signaling (Isaacs et al., 1994).
oss of XtSpreds in animal caps inhibited elongations
ith activin treatment. However, increased mesoderm
as detected in untreated Xtspred-depleted caps, indi-
ating excessive mesoderm formation consistent with
tSpreds acting as MAPK inhibitors.
Taken together, these results describe a molecular
ranching of FGFR signaling during mesoderm forma-
ion and morphogenesis: a Sprouty-sensitive pathway
ffecting PKCδ activation and Ca2+ signaling and medi-
ting morphogenesis, and a Spred-sensitive pathway
ffecting MAPK activity and mesoderm specification.
ith the identification of these two regulatory pathways
t will now be possible to dissect the various down-
tream elements involved in each branch. One impor-
ant aspect to address will be the functional roles con-
ributed by the various XtSprouty and XtSpred protein
omains in order to identify the elements regulating
heir specificity. As there is considerable divergence
etween Drosophila and vertebrate Sprouty sequences,
prouty and Spred functions may have become spe-
ialized to accomplish specific signaling tasks during
ertebrate evolution.
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Signal Interpretation
FGFR-dependent activation of the Ras/MAPK pathway
is necessary for specification of mesoderm in vivo (Si-
vak and Amaya, 2004). However, we have demon-
strated a role for FGFR signaling in the morphogenetic
cell movements that follow as well. Several other
studies have also demonstrated a role of FGFR signal-
ing in morphogenesis during gastrulation (Ciruna and
Rossant, 2001; Nutt et al., 2001; Yang et al., 2002). No-
tably, we have shown here that although FGFR function
is required, MAPK is not active during the majority of
morphogenesis in the early embryo. Therefore a devel-
opmental switch to a different FGFR signaling pathway
must be made to mediate this function.
All four Xtsproutys and Xtspreds analyzed had largely
overlapping expression patterns. However, we found
variations over time, which has important implications
for the regulation of FGFR signaling. Expression of
Xtspry1 and 2 are relatively stronger during early gas-
trulation, peaking by stage 10.5, after which expression
levels are reduced. In contrast, Xtsprd1 and 2 are ex-
pressed at lower levels during early gastrulation but
rise after stage 12, when morphogenesis predominates.
When these temporal differences are compared with
the signaling pathways targeted by each gene family, a
model of FGFR signal switching can be proposed (Fig-
ure 7).
During the early stages of gastrulation, FGFR signal-
ing is necessary to maintain specification of mesoder-
mal tissues. At this time, Xtsproutys are strongly ex-
pressed and inhibit the PLCγ pathway regulating
morphogenetic movements. Consequently, the pre-
dominant signal transduced downstream of the FGFR
is the ras/MAPK pathway, leading to transcription of
mesodermal genes such as Xbra. As gastrulation pro-
ceeds, Xtsprouty transcription decreases and Xtspred
transcription increases. As a result, the ras/MAPK path-
way is inhibited and the predominant pathway is
switched toward regulation of morphogenesis. A key
advantage of this mechanism is that FGF signal inter-
pretation occurs relatively quickly at the cell membrane
to allow for plastic and responsive changes to events
during a rapid early developmental timescale. However,
this model may be complicated by positive and/or
negative feedback due to the fact that Sproutys, and
likely Spreds, are themselves downstream targets of
FGFR signaling (Minowada et al., 1999; Nutt et al., 2001).
In conclusion, we have uncovered consistent func-
tional differences between XtSprouty and XtSpred
proteins downstream of the FGFR that are used to co-
ordinate FGF signal interpretation during vertebrate mor-
phogenesis. It will be interesting to discover if similar
mechanisms are involved in regulating other examples
of RTK activity.
Experimental Procedures
Isolation of Xtsprouty and Xtspred Genes
and Construct Design
X. tropicalis Sprouty-related homologs were identified through
searches of the Wellcome Trust Full Length Database against hu-
man and X. laevis EST sequences. Four genes were identified:
Xtsprouty1 (Xtspry1; clone TNeu048o16), Xtsprouty2 (Xtspry2;TGas112n24), Xtspred1 (Xtsprd1; TNeu018m17), and Xtspred2
(Xtsprd2; TGas019j20). Full-length clones were purified from corre-
sponding EST libraries (Gilchrist et al., 2004). In some cases extra-
neous sequence was deleted to remove unwanted regulatory ele-
ments. The Xtspry1 clone TGas112n24 was missing 86 bases of
coding sequence at the 5# end, which was replaced by searching
the JGI X. tropicalis Genomic Database to identify the correspond-
ing sequence. GenBank accession numbers are as follows:
Xtspry1, AY714335; Xtspry2, AY714336; Xtsprd1, AY714338;
Xtsprd2, AY714337). In situ hybridizations were performed accord-
ing to established protocols using antisense DIG-labeled probes.
Dominant-negative FGF receptor (XFD), nonfunctional FGF re-
ceptor (HAV\), constitutively active FGFR1 (pCIXR), and its corre-
sponding dominant-negative (pCIXD) have been previously de-
scribed (Amaya et al., 1991; Nutt et al., 2001). Full-length X. laevis
PKCδ1 was obtained from the I.M.A.G.E. Consortium (Invitrogen/
Resgen, 4969220) and subcloned into the StuI and XhoI sites of the
pCSGFP3-TAA vector to generate an N-terminal PKCδ-GFP fusion.
RNA Synthesis and Embryo Microinjections
Capped mRNA was synthesized using the mMessage Machine kit
according to the manufacturer’s directions (Ambion). Embryos were
cultured and injected with RNAs according to established protocol.
Developmental staging was assessed as described (Nieuwkoop
and Faber, 1967). Generally, 100 pg of nuclear localized β-galacto-
sidase (pnucβ-gal) or GFP RNA were coinjected as a lineage tracer.
For animal cap experiments, embryos were injected at animal poles
and cap tissue was excised at stage 8. Caps were then incubated
in either 0.4× MMR (for extension experiments) or 1× MMR (for
MAPK assay). Human recombinant activin A (R&D Systems) was
added at 10 ng/ml, and FGF2 (a gift of Dr. Harry Isaacs) was added
at 100 ng/ml.
FGFR and MAPK Inhibitor Treatments
Embryos were cultured to stage 8 or 12.5 and injected into the
blastocoel with 10 nl of a 2 mM DMSO stock of either SU5402
(Calbiochem), an FGFR1 kinase activity inhibitor, or U0126 (Calbio-
chem), a MEK1 inhibitor, and cultured in 0.1× MMR with 20 M of
the corresponding inhibitor. Embryos treated at stage 8 were fixed
at stages 11.5 and 29–30 for in situ hybridization. Embryos treated
at stage 12.5 were fixed at stage 31 and photographed.
Cellular Localization Assay
100 pg PKCδ-GFP mRNA was coinjected into X. laevis animal poles
with Xtspry2 or Xtsprd1. Animal caps were excised at stage 9 in 1×
modified Danilchik’s medium (DFA) to prevent healing (Sater et al.,
1994) and were cultured for 10 min in 1× DFA with or without 100
ng/ml FGF2 or 1 M PMA (Sigma). Caps were lightly fixed in formal-
dehyde for 20 min and GFP localization was determined by confo-
cal microscopy.
Morpholino Design and Microinjections
MOs were purchased from Gene Tools LLC. RNA splice junctions
were identified by alignment of cDNA sequences with matching
genomic sequences. X. tropicalis embryos were injected with 10
ng total MOs before first cleavage, and were generally coinjected
with a fluorescent control MO (Li std; Gene Tools). MO sequences
are listed as follows. ATG MOs: 4-mis Spry2, 5#-GCCTTTTAG
TACTCTCGTGTCCTTC-3# (mismatch bases are bold); Spry2 ATG,
5#-GCCATTTTGTACTCTCGTCTCCATC-3#; Sprd1 ATG, 5#-CCTGTT
CGCCGCTCATTGTCCCCTT-3#; Sprd2 ATG, 5#-TCCTCGCTCATT
TTGTCCCTGCTCA-3#; Splice MOs (intron sequences are lower
case): Spry1 i1e2, 5#-CATCTGAAAACctgccgatcaaaac-3#; Spry2
e1i1, 5#- gtacttacCGTGACCTCCTCGCCCC-3#; Sprd1 e1i1, 5#-ggtg
gcactcacTCTGGCTCCTGTT-3#; Sprd2 e2i2, 5#-ttccttaCCAGTTTG
TCATTCAGTC-3#.
RNA Isolation and RT-PCR
Total RNA was isolated from embryos and animal caps using the
TRIzol reagent according to manufacturer’s instructions (Invitro-
gen). cDNA was synthesized using AMV reverse transcriptase
(Roche), and PCR reactions were performed using Taq polymerase
(Roche) according to established protocol. Primer sequences are
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700written 5# to 3# as follows. Xtspry1 forward, CGCAGTTCCGATCG S
sGATTTGC; reverse, CACTATTTGTGCTACCAGAAC; Xtspry2 f, CAT
GCGAATTCATGGAGACGAGAGTAC; r, GTGTGGCGTAGTCTGTCG G
TGG; Xtsprd1 f, CGCACTTCCCATATAACCTC; r, CCTGTGGTCCA a
TCCTCAGAAG; Xtsprd2 f, GACGGTCCTCTTCGATGCTGC; r, CCA a
AGCTCTGCCTCATTATGG; Xbra f, AGACATCTTGGATGAGGG; r,
G
GAAGGGTACTGACTTGAG. Xtwnt11 f, TACTCATCTTGTGCTGCTC
5
CAGG; r, ACAAGCACGAGCAATGGTATGG; Xtwnt8 f, CTGAAGATC
GAAGCACGACCA; r, CAGCTCCTTCTTTCCCACTG. Control primers
tfor EF1α (Hemmati-Brivanlou and Melton, 1994) and ornithine de-
acarboxylase (ODC) (Heasman et al., 2000) have been previously de-
gscribed. Real-time RT-PCR analysis was performed using a Light-
GCycler SystemTM (Roche).
J
w45Ca2+ Efflux Assay
HOocytes were isolated, injected, and cultured for 48 hr in modified
MBarth’s saline (MBSH) at 16°C and then assayed for 45Ca2+ efflux
tas described (Musci et al., 1990). 10 ng of each RNA was injected
2along with 1 ng of pCIXR, a constitutively active FGF receptor (Nutt
et al., 2001). H
S
MImmunoblotting
For assays of MAPK activity, 10 embryos or animal caps were ho- H
mogenized in 1× RIPA lysis buffer with the addition of Complete E
protease inhibitor cocktail (Roche) and 50 mM sodium fluoride and p
10 mM sodium orthovanadate to inhibit phosphatase activity. In p
whole embryos, freon was used to extract yolk proteins according 2
to established protocol. Western blots were probed with 1:10000 H
mouse anti-dpMAPK (clone MAPK-YT, Sigma) or 1:2000 mouse C
anti-panMAPK (Clone 16, Transduction Laboratories) according to s
established protocols. 1
H
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